Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.

ABSTRACT:

Background

Attention deficit hyperactivity disorder (ADHD) affects approximately 3% of adults globally. Many pharmacologic treatments options exist, yet the comparative benefits and harms of individual treatments are largely unknown. We performed a systematic review and network meta-analysis to assess the relative effects of individual pharmacologic treatments for adults with ADHD.

Methods

We searched English-language published and grey literature sources for randomized clinical trials (RCTs) involving pharmacologic treatment of ADHD in adults (December 2018). The primary outcome was clinical response; secondary outcomes were quality of life, executive function, driving behaviour, withdrawals due to adverse events, treatment discontinuation, serious adverse events, hospitali

SUBMITTER: Elliott J 

PROVIDER: S-EPMC7577505 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature